海普瑞 (002399)
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO.,LTD.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 146729.62
- Circulating A-Shares(W): 124720.17
- Earnings Per Share(RMB): 0.3773
- Net Assets Per Share(RMB): 8.4302
- Operating Revenue(W RMB): 419446.44
- Total Profit(W RMB): 64159.91
- Net Profit Attributable to Parent(W RMB): 55357.57
- Net Profit Growth Rate(%): -29.04
- Weighted Return on Equity(%): 4.5100
- Operating Cash Flow Per Share(RMB): 0.9820
- Undistributed Profit Per Share(RMB): 2.8757
- Capital Reserve Per Share(RMB): 3.9964
2. Main Business
The main business covers:
- Heparin industry chain
- Biologics CDMO
- Investment, development and commercialization of innovative drugs
3. Company Basic Information
- Company Name: Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Listing Date: 2010-05-06
- Industry: Pharmaceutical Manufacturing
- Address: No. 21 Langshan Road, Songpingshan, Nanshan District, Shenzhen City, Guangdong Province
- Website: www.hepalink.com
- Company Profile: The company was established as a joint-stock company through the overall restructuring of Shenzhen Hepalink Pharmaceutical Co., Ltd., approved by the Ministry of Commerce.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Shenzhen Leren Technology Co., Ltd. | General Legal Person | 47402.99 | 38.01 |
| 2 | Gongqingcheng Jintiantu Investment Partnership (Limited Partnership) | General Legal Person | 40804.13 | 32.72 |
| 3 | Gongqingcheng Shuideshichuan Investment Partnership Enterprise (Limited Partnership) | General Legal Person | 4642.56 | 3.72 |
| 4 | Gongqingcheng Feilaishi Investment Co., Ltd. | General Legal Person | 4032.00 | 3.23 |
| 5 | Shenzhen Hepalink Pharmaceutical Co., Ltd. - Phase II Employee Stock Ownership Plan | General Legal Person | 1511.80 | 1.21 |
| 6 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 1200.93 | 0.96 |
| 7 | Shenzhen Hepalink Pharmaceutical Group Co., Ltd. - Phase III Employee Stock Ownership Plan | Asset Management Plan | 388.63 | 0.31 |
5. Concept Sectors
- H-Share
- Biological Vaccine
- CXO Concept
- Innovative Drug
- Margin Trading & Securities Lending
- MSCI Mid Cap
- Overseas Business
- Small Cap Value
- SZSE Value Index
- SME 300
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information